Onfi (Lundbeck Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Onfi drug offered from Lundbeck Pharmaceuticals LLC. This Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lundbeck Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | clobazam |
SUBSTANCE NAME: | CLOBAZAM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Cytochrome P450 2D6 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-12-14 |
END MARKETING DATE: | 0000-00-00 |
Onfi HUMAN PRESCRIPTION DRUG Details:
Item Description | Onfi from Lundbeck Pharmaceuticals LLC |
LABELER NAME: | Lundbeck Pharmaceuticals LLC |
DEA SCHEDULE: | CIV
|
ACTIVE STRENGTH: | 2.5(mg/mL) |
START MARKETING DATE: | 2012-12-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67386-313_58d32c2a-ca28-49cb-98f5-57cee4f42b42 |
PRODUCT NDC: | 67386-313 |
APPLICATION NUMBER: | NDA203993 |
Other CLOBAZAM Pharmaceutical Manufacturers / Labelers: